Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-24 @ 10:34 PM
NCT ID:
NCT00713635
Eligibility Criteria:
Inclusion Criteria:
1. All women who present to Columbia University Medical Center between 18-24 wks gestational age with the following fetal diagnoses will be invited to participate:
2. Hypoplastic Left Heart Syndrome (HLHS)
3. Transposition of the Great Arteries (TGA)
4. Tetralogy of Fallot (TOF)
5. Lung anomalies consisting of either congenital cystic adenomatoid malformations or bronchogenic cysts
Exclusion Criteria:
1. Documented fetal chromosomal anomaly
2. Structural brain malformations
3. Evidence of placental insufficiency or Intrauterine growth retardation
4. Documented hydrops fetalis or sustained cardiac arrhythmias
5. Anticipated delivery at an outside hospital
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
50 Years
Study:
NCT00713635
Study Brief:
Protocol Section:
NCT00713635